These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 5612197)

  • 41. [Effect of cycloserine, ethionamide, and ethoxyd on liver function in pulmonary tuberculosis].
    Baĭl'dinova IM
    Ter Arkh; 1971 Jan; 43(1):101-4. PubMed ID: 5574526
    [No Abstract]   [Full Text] [Related]  

  • 42. [Late results of treatment of chronic, cavernous pulmonary tuberculosis with reserve drugs].
    Zierski M; Zachara A
    Gruzlica; 1968; 37(1):31-8. PubMed ID: 5720035
    [No Abstract]   [Full Text] [Related]  

  • 43. Efficacy and safety of kanamycin, ethionamide, PAS and cycloserine in multidrug-resistant pulmonary tuberculosis patients.
    Prasad R; Verma SK; Sahai S; Kumar S; Jain A
    Indian J Chest Dis Allied Sci; 2006; 48(3):183-6. PubMed ID: 18610675
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The place of the thioamides in the treatment of pulmonary tuberculosis. (Role of TH 1321)].
    Molina C; Cheminat JC; Petit R
    Sem Hop; 1966 Jan; 42(2):99-105. PubMed ID: 4285613
    [No Abstract]   [Full Text] [Related]  

  • 45. [Comparison of the effect of morphazinamide and pyrazinamide in the treatment of chronic tuberculosis].
    Zierski M
    Gruzlica; 1965 Sep; 33(9):769-71. PubMed ID: 5859903
    [No Abstract]   [Full Text] [Related]  

  • 46. [Variations of transaminases and blood sugar in pulmonary tuberculosis patients under different chemotherapy schemes].
    Rosemberg J; Dini W; Accetozi M; Cassoni Tde A; Inaco BJ; Garlipp W; Romanoff JS
    AMB Rev Assoc Med Bras; 1974 Jul; 20(7):243-8. PubMed ID: 4547118
    [No Abstract]   [Full Text] [Related]  

  • 47. [Use of thioamides in primary and post-primary tuberculosis in children with the exclusion of meningitis].
    Gerbeaux J; Baculard A
    Bull Mem Soc Med Hop Paris; 1965 Nov; 116(15):1575-89. PubMed ID: 5295353
    [No Abstract]   [Full Text] [Related]  

  • 48. [Comparison between morphazinamide and pyrazinamide in retreatment of pulmonary tuberculosis].
    Zierski M
    Minerva Med; 1965 Sep; 56(71):2953-4. PubMed ID: 5322283
    [No Abstract]   [Full Text] [Related]  

  • 49. Pyrazinamide deamidase activity in tuberculous disease.
    Gurumurthy P; Krishnamurthy PV; Garhupati Sarma G
    Am Rev Respir Dis; 1981 Jul; 124(1):97. PubMed ID: 7020509
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Observations on antituberculous drug-resistance among pulmonary tuberculosis patients at the National Sanatoria in Kyushu district. 3. The secondary anti-tuberculosis agents (kanamycin, cycloserine, ethionamide)].
    Yamaguchi S
    Iryo; 1968 Oct; 22(10):1115-9. PubMed ID: 5715475
    [No Abstract]   [Full Text] [Related]  

  • 51. [Treatment with antibacterial preparations and tuberculin of patients with destructive forms of pulmonary tuberculosis].
    Rakhmanov KhKh
    Vrach Delo; 1967 May; 5():83-7. PubMed ID: 5618552
    [No Abstract]   [Full Text] [Related]  

  • 52. [Metabolism of morphazinamide in patients with pulmonary tuberculosis].
    Zierski M
    Minerva Med; 1965 Sep; 56(70):2759-62. PubMed ID: 5852634
    [No Abstract]   [Full Text] [Related]  

  • 53. [Serum aminotransferase activity in pulmonary tuberculosis during chemotherapy with tubazid].
    Gol'dshteĭn VD; Fondaminskaia LD
    Vopr Med Khim; 1972; 18(2):172-6. PubMed ID: 4679613
    [No Abstract]   [Full Text] [Related]  

  • 54. International conference.
    Tubercle; 1967 Dec; 48(4):339-43. PubMed ID: 5588949
    [No Abstract]   [Full Text] [Related]  

  • 55. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
    Bwire R; Borgdorff MW; Sticht-Groh V; Rieder HL; Kawuma HJ; Bretzel G; Rüsch-Gerdes S
    East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Change in the lactate dehydrogenase activity in the blood of patients with pulmonary tuberculosis during antibacterial therapy].
    Khaiutina ES
    Probl Tuberk; 1978 Aug; (8):42-6. PubMed ID: 704582
    [No Abstract]   [Full Text] [Related]  

  • 57. [Specific features of the course of pulmonary tuberculosis concurrent with liver pathology].
    Krasnov VA; Ron'zhina EG; Petrenko TI; Romanov VV; Kharlamova IuM; Muzyko LV; Filimonov PN; Tolokonskaia NP; Kozhevnikov VS; Kurunov IuN
    Probl Tuberk Bolezn Legk; 2003; (4):26-8. PubMed ID: 12774415
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Experiences with antitubercular agents of the second line].
    Zierski M
    Wien Med Wochenschr; 1966 Oct; 116(40):824-7. PubMed ID: 5927179
    [No Abstract]   [Full Text] [Related]  

  • 59. [Tuberculostatics. 1].
    Protivinsky R
    Ther Ggw; 1968 Nov; 107(11):1443-6 passim. PubMed ID: 5753422
    [No Abstract]   [Full Text] [Related]  

  • 60. [Determination of Mycobacterium tuberculosis' sensitivity to pyrazinamide on a BACTEC-960 bacteriological analyzer].
    Irtuganova OA; Smirnova NS; Slogotskaia LV
    Probl Tuberk Bolezn Legk; 2003; (7):40-2. PubMed ID: 12939878
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.